Smart Perfusion
Smart Perfusion's mission is to reduce the wait list for kidney and liver transplants by increasing the yield from a large donor pool.
- Stage Product In Development
- Industry Medical Devices and Equipment
- Location United States
- Currency USD
- Employees 0
- Website smartperfusion.com
Company Summary
VasoWave is the embodiment of patented and patent pending technology that rinses organs effectively and extends kidney perfusion from less than 24 hours to 72 hour and liver perfusion from less than 12 hours to 24 hours. Transplant surgeons will have access to quantifiable organ assessment data prior to implant. Customers are transplant professionals in Organ Procurement Organizations and Transplant Centers.
Team
-
George Barr
Mr. Barr is a founder and President. He has over thirty years of successful technology commercialization experience. Mr. Barr has a BA from Washington and Lee University and an MBA from Virginia Tech.
-
Don Faulkner
CTO Don Faulkner is an engineer who specializes in fluid dynamics, and who has over thirty years of technology commercialization experience.
-
John L. Robertson, PhD, VMDDr.
CSO John L. Robertson, VMD and PhD (Nephrology) has extensive experience in academia, industry and FDA.
-
David Gerber, MDDr.
CMO David A. Gerber, MD is Chief of Transplantation, University of North Carolina at Chapel Hill.
Advisors
-
GreenbergTraurigLawyerUnconfirmedMcCannon Rogers Driscoll & Associates L L PAccountantUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.